73 related articles for article (PubMed ID: 22245179)
1. Do medical interventions for traumatic hyphema reduce the risk of vision loss?
Kirschner J; Seupaul RA
Ann Emerg Med; 2012 Aug; 60(2):197-8. PubMed ID: 22245179
[No Abstract] [Full Text] [Related]
2. Traumatic hyphema: a comprehensive review.
Brandt MT; Haug RH
J Oral Maxillofac Surg; 2001 Dec; 59(12):1462-70. PubMed ID: 11732035
[No Abstract] [Full Text] [Related]
3. Atropine in the treatment of traumatic hyphema.
Gilbert HD; Jensen AD
Ann Ophthalmol; 1973 Dec; 5(12):1297-300. PubMed ID: 4769181
[No Abstract] [Full Text] [Related]
4. An analysis of risk for secondary hemorrhage in traumatic hyphema.
Rahmani B; Jahadi HR; Rajaeefard A
Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
Beiran I; Talmon T; Miller B
Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema.
Aylward GW; Dunlop IS; Little BC
Eye (Lond); 1994; 8 ( Pt 4)():440-2. PubMed ID: 7821469
[TBL] [Abstract][Full Text] [Related]
7. Outpatient management of traumatic hyphemas in children.
Coats DK; Viestenz A; Paysse EA; Plager DA
Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
[TBL] [Abstract][Full Text] [Related]
8. [Traumatic hyphema].
Talmon T; Beiran I; Miller B
Harefuah; 1997 Nov; 133(10):448-50, 502. PubMed ID: 9418318
[TBL] [Abstract][Full Text] [Related]
9. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
[TBL] [Abstract][Full Text] [Related]
10. Opposition to treatment of traumatic hyphema with antifibrinolytics/steroids.
Romano PE; Smith RJ
Binocul Vis Strabismus Q; 2000; 15(2):163-5. PubMed ID: 10893458
[No Abstract] [Full Text] [Related]
11. Traumatic hyphema management: assuring compliance with outpatient care; steroidophobia: rational or irrational?
Romano PE
Binocul Vis Strabismus Q; 2000; 15(2):166-8. PubMed ID: 10893459
[No Abstract] [Full Text] [Related]
12. Antifibrinolytic agents in the management of traumatic hyphema.
Goldberg MF
Arch Ophthalmol; 1983 Jul; 101(7):1029-30. PubMed ID: 6347147
[No Abstract] [Full Text] [Related]
13. Traumatic hyphema.
Crouch ER
J Pediatr Ophthalmol Strabismus; 1986; 23(2):95-7. PubMed ID: 3958878
[TBL] [Abstract][Full Text] [Related]
14. Pro steroids for systemic antifibrinolytic treatment for traumatic hyphema.
Romano PE
J Pediatr Ophthalmol Strabismus; 1986; 23(2):92-5. PubMed ID: 3790203
[No Abstract] [Full Text] [Related]
15. Traumatic hyphema.
Witteman GJ
Arch Ophthalmol; 1984 Mar; 102(3):356-8. PubMed ID: 6703978
[No Abstract] [Full Text] [Related]
16. Traumatic hyphema: outcomes of outpatient management.
Shiuey Y; Lucarelli MJ
Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
Rahmani B; Jahadi HR
Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
[TBL] [Abstract][Full Text] [Related]
18. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
Romano PE; Robinson JA
Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
[TBL] [Abstract][Full Text] [Related]
19. The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
Bramsen T
Acta Ophthalmol Suppl; 1980; (145):1-53. PubMed ID: 6257028
[No Abstract] [Full Text] [Related]
20. Factors related to the final visual outcome of 425 patients with traumatic hyphema.
Ng CS; Sparrow JM; Strong NP; Rosenthal AR
Eye (Lond); 1992; 6 ( Pt 3)():305-7. PubMed ID: 1446766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
